|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01144858 |
|
Date of registration:
|
15/06/2010 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Clinical Value of Left Atrial Appendage Flow for Prediction of Successful Catheter Ablation for Persistent Atrial Fibrillation
CLAAAF |
|
Scientific title:
|
Clinical Value of Left Atrial Appendage Flow for Prediction of Successful Catheter Ablation for Persistent Atrial Fibrillation |
|
Date of first enrolment:
|
January 2009 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT01144858 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- First-time radiofrequency catheter ablation for pAF. pAF was defined as continuous AF
lasting longer than 1 month, resistant to either electrical or pharmacological
cardioversion.
- Informed consent
Exclusion Criteria:
- Severe valvular disease requiring surgery
- Valvular prosthesis
- Known severe coronary artery disease
- Atrial and/or ventricular thrombosis
- New York Heart Association functional class III to IV
- Cerebrovascular disease
- Pulmonary embolism
- Latent or manifest hyperthyroidism
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Persistent Atrial Fibrillation
|
|
Catheter Ablation
|
|
Intervention(s)
|
|
Other: a complete transesophageal echocardiography
|
|
Primary Outcome(s)
|
|
termination of persistent AF by catheter ablation
[Time Frame: Yes]
|
|
Secondary Outcome(s)
|
|
Recurrences of AF were therefore determined from holter monitoring at 3 and 6 months or 12 leads ECG in care of symptomatic palpitation with clinical interview.
[Time Frame: Yes]
|
|
Secondary ID(s)
|
|
past-1001-ryth
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|